Christine Garrett
Corporate Officer/Principal chez LEO Pharma A/S
Profil
Christine Garrett is currently the Vice President & Head-Global Project Management at LEO Pharma A.
Previously, she held the position of Head-Late Development Project Management at Bristol Myers Squibb Co. and Chief of Staff & Senior Vice President-Operations at Graphite Bio, Inc. She holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the Rochester Institute of Technology.
Postes actifs de Christine Garrett
Sociétés | Poste | Début |
---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Anciens postes connus de Christine Garrett
Sociétés | Poste | Fin |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
LENZ THERAPEUTICS, INC. | Chief Operating Officer | - |
Formation de Christine Garrett
Massachusetts Institute of Technology | Doctorate Degree |
Rochester Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 2 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |